Methylcobalamin is notoriously light-sensitive and can degrade rapidly when exposed to ambient conditions, potentially reducing the effective B12 dose you receive with each injection
Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses
Recently, Eli Lilly reported they anticipate submitting Orforglipron for FDA approval in the second half of 2025, with potential availability shortly after if approved
DPP-4 inhibitors did not lower the risk of any cardiorenal outcome when compared with placebo and were associated with higher risks of MACE, HHF, and renal outcome when compared with the other two drug classes
This attention to timing maximizes benefits while respecting circadian biology
Research shows that protein intake during GLP-1 therapy is critical, but glycine adds an additional layer of protection at the cellular level